Successful treatment of platelet transfusion refractoriness. The use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized leukaemia patients

被引：0
|
作者：
Kekomaki, S
Volin, L
Koistinen, P
Koivunen, E
Timonen, T
Kekomaki, R
机构：
[1] FINNISH RED CROSS & BLOOD TRANSFUS SERV, SF-00310 HELSINKI, FINLAND
[2] UNIV HELSINKI HOSP, HELSINKI, FINLAND
[3] OULU UNIV HOSP, OULU, FINLAND
[4] TAMPERE UNIV HOSP, TAMPERE, FINLAND
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：PS315 / PS315
页数：1
相关论文
共 35 条
  • [31] Human platelet alloantigens system haplotype (HPA-1, HPA-2, HPA-3, and HPA-4) are associated with ischemic stroke in adult Tunisian stroke patients
    Saidi, S.
    Almawi, W. Y.
    Ben Slamia, L.
    Ben Ammou, S.
    Mahjoub, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 189 - 189
  • [32] Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis
    Al-Subaie, Abeer M.
    Fawaz, Naglaa A.
    Mahdi, Najat
    Al-Absi, Iman K.
    Al-Ola, Khadija
    Ameen, Ghada
    Almawi, Wassim Y.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (06) : 579 - 585
  • [33] A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients
    Vo, Phuong
    Purev, Enkhtsetseg
    West, Kamille A.
    McDuffee, Emily
    Worthy, Tatyana
    Cook, Lisa
    Hawks, Geri
    Wells, Brian
    Shalabi, Reem
    Flegel, Willy A.
    Adams, Sharon D.
    Reger, Robert
    Aue, Georg
    Tian, Xin
    Childs, Richard
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (03) : 551 - 558
  • [34] Human Leukocyte Antigen Class I (HLA-I) Antibodies in Patients Undergoing Liver Transplantation: Implications for Platelet Transfusion Support.
    Wong, M.
    Narra, R.
    Selim, M.
    Zimmerman, M. A.
    Padmanabhan, A.
    Hung, J. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 642 - 642
  • [35] The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders
    Peon, Man-Chiu
    TRANSFUSION MEDICINE REVIEWS, 2007, 21 (03) : 223 - 236
1234